Digoxin tablet
Sponsors
Boehringer Ingelheim, Biogen, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Jiangsu HengRui Medicine Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions
Advanced Solid TumorDiabetes Mellitus, Type 2HealthyHealthy Adult SubjectsHealthy SubjectsNon-Medullary Thyroid CarcinomaNonalcoholic SteatohepatitisOverweight
Phase 1
Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers
CompletedNCT02243553
Start: 2006-01-31Updated: 2014-09-18
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
CompletedNCT04008186
Start: 2019-06-14End: 2019-08-28Updated: 2025-05-30
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects
CompletedNCT04322552
Start: 2020-03-12End: 2021-05-03Updated: 2022-11-07
A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy Subjects
CompletedNCT05045313
Start: 2021-10-20End: 2021-12-01Updated: 2022-03-10
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
CompletedNCT06247748
Start: 2023-10-19End: 2024-04-15Updated: 2024-08-21